wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q37342909-159574F2-B779-4171-9E8E-189D0B473B4C
Q37342909-159574F2-B779-4171-9E8E-189D0B473B4C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37342909-159574F2-B779-4171-9E8E-189D0B473B4C
Evaluation of Novel Targeted Therapies in Aggressive Biology Sarcoma Patients after progression from US FDA approved Therapies.
P2860
Q37342909-159574F2-B779-4171-9E8E-189D0B473B4C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37342909-159574F2-B779-4171-9E8E-189D0B473B4C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
95895d97f8feedda63d9fa838ee32fdd5ad18e28
P2860
Contrast of response to dacarbazine, mitomycin, doxorubicin, and cisplatin (DMAP) plus GM-CSF between patients with advanced malignant gastrointestinal stromal tumors and patients with other advanced leiomyosarcomas.